WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Shubham Dutta
PeerJ Reviewer
15 Points

Contributions by role

Reviewer 15

Contributions by subject area

Bioinformatics
Cell Biology
Molecular Biology
Oncology

Shubham Dutta

PeerJ Reviewer

Summary

I am a Scientist II at Massachusetts Biological Laboratory (MassBiologics of UMMS). I have earned his Ph.D. in Biomedical Sciences degree in 2018 from the University of Massachusetts Medical School and then worked as a Senior Scientist in a Cambridge based biotechnology company. I have a broad research background and 8+ years of experience in Oncology, Molecular biology, Gene editing, CRISPR, Biochemistry, and Immunology. My current research focuses on understanding the cellular, biochemical, and molecular basis of cancer and certain rare genetic disorders and how genetic and epigenetic programming contribute to the progression of these diseases. I have undertaken a variety of functional genomics approaches such as RNA interference (RNAi) and CRISPR-based screens, proteomics, and biochemistry-based methods to identify new genes, proteins, and regulatory pathways that are the cause of or contribute to the disease state. Another area of my research is to design novel antibodies that can be in vaccination against SARS, Zika, coronavirus, and developing non-human primate models for these diseases. I am also serving on the editorial boards in several peer-reviewed journals.

Biochemistry Bioengineering Bioinformatics Biotechnology Cell Biology Developmental Biology Genetics Genomics HIV Immunology Infectious Diseases Microbiology Molecular Biology Oncology Pharmacology

Past or current institution affiliations

University of Massachusetts Medical School

Work details

Scientist II

University of Massachusetts Medical School
September 2020
Department of Medicine

Graduate Student

University of Massachusetts Medical School
September 2011 - March 2018
Biochemistry and Molecular Pharmacology

Post-Doctoral Associate

University of Massachusetts Medical School
May 2018 - September 2018
Molecular Cell and Cancer Biology

Scientist II

Totient Inc
September 2018 - January 2020
Immu-Oncology

Websites

  • Google Scholar
  • LinkedIn

PeerJ Contributions